Cargando…
MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction
The accurate prediction of drug–target binding affinity (DTA) is an essential step in drug discovery and drug repositioning. Although deep learning methods have been widely adopted for DTA prediction, the complexity of extracting drug and target protein features hampers the accuracy of these predict...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179712/ https://www.ncbi.nlm.nih.gov/pubmed/37176031 http://dx.doi.org/10.3390/ijms24098326 |
_version_ | 1785041162799677440 |
---|---|
author | Wang, Shudong Song, Xuanmo Zhang, Yuanyuan Zhang, Kuijie Liu, Yingye Ren, Chuanru Pang, Shanchen |
author_facet | Wang, Shudong Song, Xuanmo Zhang, Yuanyuan Zhang, Kuijie Liu, Yingye Ren, Chuanru Pang, Shanchen |
author_sort | Wang, Shudong |
collection | PubMed |
description | The accurate prediction of drug–target binding affinity (DTA) is an essential step in drug discovery and drug repositioning. Although deep learning methods have been widely adopted for DTA prediction, the complexity of extracting drug and target protein features hampers the accuracy of these predictions. In this study, we propose a novel model for DTA prediction named MSGNN-DTA, which leverages a fused multi-scale topological feature approach based on graph neural networks (GNNs). To address the challenge of accurately extracting drug and target protein features, we introduce a gated skip-connection mechanism during the feature learning process to fuse multi-scale topological features, resulting in information-rich representations of drugs and proteins. Our approach constructs drug atom graphs, motif graphs, and weighted protein graphs to fully extract topological information and provide a comprehensive understanding of underlying molecular interactions from multiple perspectives. Experimental results on two benchmark datasets demonstrate that MSGNN-DTA outperforms the state-of-the-art models in all evaluation metrics, showcasing the effectiveness of the proposed approach. Moreover, the study conducts a case study based on already FDA-approved drugs in the DrugBank dataset to highlight the potential of the MSGNN-DTA framework in identifying drug candidates for specific targets, which could accelerate the process of virtual screening and drug repositioning. |
format | Online Article Text |
id | pubmed-10179712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101797122023-05-13 MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction Wang, Shudong Song, Xuanmo Zhang, Yuanyuan Zhang, Kuijie Liu, Yingye Ren, Chuanru Pang, Shanchen Int J Mol Sci Article The accurate prediction of drug–target binding affinity (DTA) is an essential step in drug discovery and drug repositioning. Although deep learning methods have been widely adopted for DTA prediction, the complexity of extracting drug and target protein features hampers the accuracy of these predictions. In this study, we propose a novel model for DTA prediction named MSGNN-DTA, which leverages a fused multi-scale topological feature approach based on graph neural networks (GNNs). To address the challenge of accurately extracting drug and target protein features, we introduce a gated skip-connection mechanism during the feature learning process to fuse multi-scale topological features, resulting in information-rich representations of drugs and proteins. Our approach constructs drug atom graphs, motif graphs, and weighted protein graphs to fully extract topological information and provide a comprehensive understanding of underlying molecular interactions from multiple perspectives. Experimental results on two benchmark datasets demonstrate that MSGNN-DTA outperforms the state-of-the-art models in all evaluation metrics, showcasing the effectiveness of the proposed approach. Moreover, the study conducts a case study based on already FDA-approved drugs in the DrugBank dataset to highlight the potential of the MSGNN-DTA framework in identifying drug candidates for specific targets, which could accelerate the process of virtual screening and drug repositioning. MDPI 2023-05-05 /pmc/articles/PMC10179712/ /pubmed/37176031 http://dx.doi.org/10.3390/ijms24098326 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wang, Shudong Song, Xuanmo Zhang, Yuanyuan Zhang, Kuijie Liu, Yingye Ren, Chuanru Pang, Shanchen MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction |
title | MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction |
title_full | MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction |
title_fullStr | MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction |
title_full_unstemmed | MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction |
title_short | MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction |
title_sort | msgnn-dta: multi-scale topological feature fusion based on graph neural networks for drug–target binding affinity prediction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179712/ https://www.ncbi.nlm.nih.gov/pubmed/37176031 http://dx.doi.org/10.3390/ijms24098326 |
work_keys_str_mv | AT wangshudong msgnndtamultiscaletopologicalfeaturefusionbasedongraphneuralnetworksfordrugtargetbindingaffinityprediction AT songxuanmo msgnndtamultiscaletopologicalfeaturefusionbasedongraphneuralnetworksfordrugtargetbindingaffinityprediction AT zhangyuanyuan msgnndtamultiscaletopologicalfeaturefusionbasedongraphneuralnetworksfordrugtargetbindingaffinityprediction AT zhangkuijie msgnndtamultiscaletopologicalfeaturefusionbasedongraphneuralnetworksfordrugtargetbindingaffinityprediction AT liuyingye msgnndtamultiscaletopologicalfeaturefusionbasedongraphneuralnetworksfordrugtargetbindingaffinityprediction AT renchuanru msgnndtamultiscaletopologicalfeaturefusionbasedongraphneuralnetworksfordrugtargetbindingaffinityprediction AT pangshanchen msgnndtamultiscaletopologicalfeaturefusionbasedongraphneuralnetworksfordrugtargetbindingaffinityprediction |